Clinical Trials Arena on MSN12h
Elypta’s urine test identifies 90% of recurrent kidney cancer cases
The AUR87A study found that urine collected biomarkers could accurately predict recurrence of kidney cancer in post-surgery ...
Vietnam Investment Review on MSN16h
Innovent Biologics: Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for Platinum-resistant Ovarian Cancer
SAN FRANCISCO and SUZHOU, China, March 23, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that ...